KYMR- Kymera Therapeutics, Inc.

Name: Kymera Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kymera Therapeutics, Inc. (KYMR) has 15 insiders with recent SEC Form 4 filings, including 10 buys and 42 sells. KYMR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Baker Bros. Advisors LP	7.96M	$719.45M	-
Dir	Bvf Partners L P/il	2.22M	$200.74M	-
Dir	Booth Bruce	685.4K	$61.98M	-
CEO	Mainolfi Nello	666.2K	$60.24M	-
CFO	Jacobs Bruce N.	306.6K	$27.73M	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 3, 2023	Bvf Partners L P/il59	Director, See Remarks And Footnotes	Buy	414,105	$12.80	$5,301,325.49	+4.4%	+129.0%	+225.6%
Mar 2, 2023	Caughey Elaine	Chief Business Officer	Sell	714	$31.00	$22,131.73	-1.8%	-9.3%	+34.1%
Mar 2, 2023	Gollob Jared70	Chief Medical Officer	Sell	1,298	$31.00	$40,233.28	-0.9%	-9.3%	+34.1%
Mar 2, 2023	Jacobs Bruce N.74	Chief Financial Officer	Sell	1,370	$31.00	$42,465.29	-0.6%	-9.3%	+34.1%
Jan 12, 2023	Booth Bruce70	Director	Sell	126,474	$30.22	$3,821,738.64	-1.1%	-5.7%	-16.3%
Jan 12, 2023	Atlas Venture Fund X, L.P.69	10% Owner	Sell	126,474	$30.22	$3,821,738.64	-1.1%	-5.7%	-16.3%
Jan 12, 2023	Bvf Partners L P/il59	Director, See Remarks And Footnotes	Buy	41,007	$30.51	$1,251,190.77	+0.5%	-5.7%	-16.3%
Dec 15, 2022	Booth Bruce70	Director	Sell	382,244	$31.36	$11,985,953.69	-1.0%	+11.6%	-6.5%
Dec 15, 2022	Atlas Venture Fund X, L.P.69	10% Owner	Sell	382,244	$31.36	$11,985,953.69	-1.0%	+11.6%	-6.5%
Nov 3, 2022	Booth Bruce70	Director	Sell	220,016	$30.01	$6,602,952.38	-1.7%	+18.3%	-53.8%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC